Endpoints in trials for clinical liver transplantation

Kenneth Washburn

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

One balanced approach for assessing newer immunosuppressive therapies might be to use composite endpoints, combining conventional endpoints (graft loss, death, acute rejection) with contemporary endpoints (renal function, histological indices). A re-assessment of contemporary control groups is warranted.

Original languageEnglish (US)
Pages (from-to)252-256
Number of pages5
JournalCurrent Opinion in Organ Transplantation
Volume13
Issue number3
DOIs
StatePublished - Jun 1 2008

Keywords

  • Clinical trials
  • Endpoints
  • Liver transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Fingerprint Dive into the research topics of 'Endpoints in trials for clinical liver transplantation'. Together they form a unique fingerprint.

  • Cite this